Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michael E Wechsler"'
Autor:
Lucia De Prado Gomez, Ian Pavord, William Busse, Christopher E Brightling, Michael E Wechsler, Klaus F Rabe, Mei Zhang, Jun Xing, Juby A Jacob-Nara, Paul J Rowe
Publikováno v:
ERJ Open Research. :00417-2022
BackgroundMany patients with asthma experience loss of lung function over time, and in certain patients this can lead to progressive obstructive patterns. similar to chronic obstructive pulmonary disease. Patients with severe asthma may experience ac
Autor:
Jonathan Corren, Christopher E. Brightling, Louis-Philippe Boulet, Celeste Porsbjerg, Michael E. Wechsler, Andrew Menzies-Gow, Christopher S. Ambrose, Bill Cook, Neil Martin, Joseph Spahn, Jean-Pierre Llanos
Publikováno v:
European Respiratory Journal. 61:2202202
Autor:
Klaus F. Rabe, Ian D. Pavord, Mario Castro, Michael E. Wechsler, Nadia Daizadeh, Upender Kapoor, Benjamin Ortiz, Amr Radwan, Robert R. Johnson, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara
Publikováno v:
European Respiratory Journal. 59:2102577
Publikováno v:
European Respiratory Review, Vol 30, Iss 162 (2021)
Asthma is a heterogenous disease, and its prevalence and severity are different in malesversusfemales through various ages. As children, boys have an increased prevalence of asthma. As adults, women have an increased prevalence and severity of asthma
Autor:
Yasutaka Nakano, Don D. Sin, Hye Yun Park, Michael E. Wechsler, David Price, Marc Miravitlles, David M. Mannino, Janice M. Leung, Joan B. Soriano, Peter A. B. Wark, Bartolome R. Celli
Publikováno v:
European Respiratory Journal. 48:664-673
Patients with asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS) have been largely excluded from pivotal therapeutic trials and, as a result, its treatment remains poorly defined and lacking firm evidence. To date, there is no uni
Autor:
Paul Newbold, Mitchell Goldman, J. Mark FitzGerald, Ian Hirsch, Yanping Wu, Eugene R. Bleecker, Michael E. Wechsler, James Zangrilli, Andrew Menzies-Gow
Publikováno v:
European Respiratory Journal. 52:1800936
Benralizumab is an anti-eosinophilic monoclonal antibody that reduces exacerbations and improves lung function for patients with severe, uncontrolled asthma with eosinophilic inflammation. We evaluated the impact of baseline factors on benralizumab e
Publikováno v:
The European Respiratory Journal
M. Tommola and colleagues raise an important and hotly debated diagnostic criterion of asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS): an age threshold of 40 years for the asthma component of ACOS. We agree with their comment
Autor:
Michael E. Wechsler, Gerard Cox
Publikováno v:
European Respiratory Journal. 44:267-267
To the Editor: We commend Chung et al. [1] for their effort on consolidating recommendations for severe asthma in the European Respiratory Society/American Thoracic Society guidelines on the definition, evaluation and treatment of severe asthma. Howe
Autor:
Timothy J. Craig, Stanley J Szefler, E. R. Sutherland, Robert F. Lemanske, Monica Kraft, Stephen P. Peters, Nizar N. Jarjour, Vernon M. Chinchilli, Eugene R. Bleecker, Joe W. Ramsdell, Susan J. Kunselman, Michael J. Walter, C.A. Sorkness, Stephen I. Wasserman, Stephen C. Lazarus, E. Israel, William J. Calhoun, Michael E. Wechsler, Pedro C. Avila, Mario Castro, Richard J. Martin, M. Reno, Reuben M. Cherniack, Bill T. Ameredes, Homer A. Boushey, T. P. Ramkumar, John V. Fahy, Loren C. Denlinger
Publikováno v:
European Respiratory Journal. 34:1212-1212